TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
One of the most reviled companies in the United States recently gave Americans yet another reason to distrust their power: A recent Goldman Sachs report reveals the company questioning whether or not curing chronic illness is compatible with a sustainable business model. In an internal report viewed by CNBC about the potential of the biotech industry and gene therapy Read More…
Not just the U.S., but the rest of the Western World, alarmingly, over the last 15 years the consistently sharp increases in child mental disorders have now reached epidemic levels. 1 in 5 children have been diagnosed with a mental health problem. In turn, more children than ever before are on psychiatric drugs. Could the Read More…
Jeff Sessions’ latest memo pushes prosecutors to seek the death penalty against drug dealers, including the ability of the government to execute owners of completely legal marijuana businesses. Seriously. (TFTP) To make America great again, Donald Trump announced last month that he will be moving forward with his plan to execute people for selling drugs. Read More…
During his recent visit to New Hampshire on 3/20/18, President Trump declared once again that the US is facing a ‘drug epidemic.’ This time he advocated the death penalty for criminal drug dealers as the solution to a national crisis that has killed over 1 million Americans since the 1990’s (when the blockbuster prescription opiate Read More…
Podcast: Play in new window | Download | EmbedSubscribe: Apple Podcasts | Email | RSSWelcome to The Daily Wrap Up, a concise show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (3/24/18). While the nation is frothing at the mouth about guns, and conveniently forgetting Read More…
If you wanted to buy a product… And the main researcher of the product was the company selling it to you… Would you automatically assume the product was safe and effective? But you see, that’s the just the beginning of the problem. Suppose the company’s research was cited thousands of times in the press, as Read More…